#news #biotech As J&J eyes approval for its one-shot COVID-19 vax, it sends off phase 3 data for a swift WHO listing

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: As J&J eyes approval for its one-shot COVID-19 vax, it sends off phase 3 data for a swift WHO listing .As J&J eyes approval for its one-shot COVID-19 vax, it sends off phase 3 data for a swift WHO listing
badams
Fri, 02/19/2021 – 08:27

from FierceBiotech: Biotech https://ift.tt/3pC0Wu6